Author + information
- Alexander Kharlamov1
The purpose was to explore cardiovascular (CV) burden in Russia outlined by high CV mortality and shorter lifespan with a focus on affordablity of the percutaneous interventions.
We overviewed data sources of 2001-2014 from Bokeria’s Cardiac Center, Russian authorities, RIA news, and NANOM-FIM trial (NCT01270139).
The CV diseases (32,552,622 CV pts, or 22.2% of the population, 2012) in Russia accounted for 54.9% of all deaths. The death rate in 2012 was 13.3 per 1,000 citizens with CV mortality of 653.9 per 100,000 in 2014 (see figure). The mean age of pts in the trial was 51.6 yr (77.2% males). 175 Russian PCI centers in 2012 implemented 205,902 angio, and 75,378 PCI (69.8% of MI, and 31.2% of angina) achieving 531 PCI per 1,000,000 population with placement of 101,451 stents (1.37 stents per PCI; 48,057 DES). 45 PCI centers were ready for IVUS (1,632; 1.8% of all PCI), OCT (773; 0.9% cases) and FFR (410; 0.5%). Russia experienced truly dramatic 16-time enhancement of the angio affordability from 107 in 2000 up to 1,715 in 2013. Exactly 90,335 coronary PCI interventions (636.6 coronary PCI with 1.37 implanted stents per one patient; transradial access – 36.9%) were implemented in 185 PCI centers (1.30 PCI centers) in 2013 with a 19.8% annual growth and a 24-time 13-year increase from 27 coronary interventions in 2000 to 636 in 2013 which is significantly lower than in Europe (average 1,871 in 2013).
Mortality statistics show the stark reality of a high CV burden in Russia which requires emerging efforts to tackle CV diseases.
OTHER: Public Health Issues